Novaremed is a biopharmaceutical company that develops NEB74S for the treatment of chronic pain.
Business Model:
Revenue: $0
Employees: 1-10
Address: Birsigstrasse 2
City: Basel
State: basel-city
Zip: 4054
Country: CH
Novaremed is a biopharmaceutical company that develops NEB74S for the treatment of chronic pain.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2021 | Private Equity Round | 1 | $50M |
The Global Emerging Markets Group The Global Emerging Markets Group |
9/2019 | Equity | $2.6M | 9/2019 | Venture Round | $2.6M | 9/2020 | Equity | $2.8M | 8/2018 | Equity | $6.1M |
---|
Announced Date | Name | Price |
---|---|---|
9/2021 | Metys Pharmaceuticals |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|